Impact of steroid and lidocaine injection in the sacroiliac joint in axial spondyloarthritis patients: a randomized controlled trial
Authors:
Open Access
- 31 August 2023
- journal article
- research article
- Published by Bulgarian Rheumatology Society in Rheumatology (Bulgaria)
- Vol. 31 (2) , 10-17
Abstract
Background: The value of steroid and lidocaine injection of the sacroiliac joint in axial spondyloarthritis patients on magnetic resonance imaging scores and clinical disease outcome measures is not yet well assessed. Patient and methods: Participants were randomly assigned into two groups; Group I received unilateral ultrasound-guided sacroiliac joint injection with .5% lidocaine hydrochloride mixed with triamcinolone. At the same time, group II received subcutaneous saline injection. All participants fulfilled the ASAS criteria for axial SpA and all had bone marrow edema of at least one sacroiliac joint at baseline. Outcomes measures were: Visual Analogue Scale (VAS), Ankylosing Spondylitis Disease Activity Score (ASDAS), Bath Ankylosing Spondylitis Functional Index (BASFI), and Spondyloarthritis Research Consortium of Canada (SPARCC) scores. Participants were assessed at baseline (before and after sacroiliac joint injection) and after three months. This clinical trial was registered on clinicaltrials.gov under the number NCT04895228. Results: In this study, a total of 61 participants were registered. There was a significant difference between both groups regarding pain, spine mobility, SPARCC, and ASDAS scores in favor of group I. Spine mobility showed the earliest improvement, followed by pain whilst SPARCC, and ASDAS scores showed improvement after three months. Higher disease activity, younger age, and shorter disease duration were all associated with better outcomes. Bilateral hip involvement was a predictor of poor response. Conclusion: Sacroiliac joint injection of lidocaine and triamcinolone in axial SpA patients is a cost-effective and practical technique for controlling pain, improving function, disease activity scores, and bone marrow edema with acceptable complications and relatively sustained effect.Keywords
This publication has 21 references indexed in Scilit:
- Ultrasound Guidance for Intra-articular Sacroiliac Joint InjectionsPain Medicine, 2020
- 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisArthritis & Rheumatology, 2019
- Stability of fatigue, pain, patient global assessment and the Bath Ankylosing Spondylitis Functional Index (BASFI) in spondyloarthropathy patients with stable disease according to the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)Rheumatology International, 2018
- Steroid vs. Platelet‐Rich Plasma in Ultrasound‐Guided Sacroiliac Joint Injection for Chronic Low Back PainPain Practice, 2016
- New Population‐Based Reference Values for Spinal Mobility Measures Based on the 2009–2010 National Health and Nutrition Examination SurveyArthritis & Rheumatology, 2014
- Ultrasound-Guided Sacroiliac Joint Injection TechniqueAmerican Journal of Physical Medicine & Rehabilitation, 2013
- Ultrasound-guided sacroiliac joint injection in patients with established sacroiliitis: precise IA injection verified by MRI scanning does not predict clinical outcomeRheumatology, 2009
- Spinal mobility in ankylosing spondylitis: reliability, validity and responsivenessRheumatology, 2004
- ASSESSMENT OF THE EFFICACY OF SACROILIAC CORTICOSTEROID INJECTIONS IN SPONDYLARTHROPATHIES: A DOUBLE-BLIND STUDYRheumatology, 1996
- Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scalePain, 1983